Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo.
Molecules. 2022 Oct 1;27(19):6500. doi: 10.3390/molecules27196500.
Molecules. 2022.
PMID: 36235036
Free PMC article.
GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.
Jiang K, Tang X, Guo J, He R, Chan S, Song X, Tu Z, Wang Y, Ren X, Ding K, Zhang Z.
Jiang K, et al.
Cancer Med. 2021 Jul;10(14):4874-4884. doi: 10.1002/cam4.4041. Epub 2021 Jun 10.
Cancer Med. 2021.
PMID: 34114373
Free PMC article.
Item in Clipboard
Cite
Cite